25 Sep, 2020 11:16 AM
Immutep Limited (the Company) is convening its 2020 Annual General Meeting (AGM) at 10:30 am (AEDT) on Tuesday, 27th October 2020.
Due to the COVID-19 pandemic and related issues, the AGM will be...read more
11 Sep, 2020 04:54 PM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) advises that it intends to hold its 2020 Annual General Meeting, (AGM) on Tuesday, 27 October 2020 commencing at 10.30am (AEDT).
The Company further advis...read more
04 Sep, 2020 08:04 AM
S&P Dow Jones Indices (“S&P DJI”) announced today the changes in the S&P/ASX Indices, effective at the open of trading on September 21, 2020. Please note that in this announc...read more
31 Aug, 2020 08:15 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) is pleased to announce that the Australian Research Council (ARC) has awarded Immutep and research partner Monash University a A$671,427 grant under the ARC&...read more
26 Aug, 2020 09:24 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, pl...read more
25 Aug, 2020 08:24 AM
IVE Group Limited (IVE or the Company) today is pleased to announce its results for the 12 months ended 30 June 2020 (FY20), a period impacted by the unprecedented volatility and uncertainty as a re...read more